AOD-9604 Research: Structural and Metabolic Mechanisms

AOD-9604 is a synthetic fragment corresponding to human growth hormone residues 177–191 with an additional N-terminal tyrosine. It is a distinct molecule from full-length growth hormone. Cox et al. (2015) describe its identity and analytical metabolism; this does not establish a catalog lot’s identity or purity.

Heffernan et al. (2001) compared obese mice, wild-type controls and beta-3 adrenergic receptor knockout mice. Chronic AOD9604 exposure changed lipid-metabolism measures and beta-3 receptor RNA expression in the studied mice; some chronic responses were absent in the knockout animals, while acute fat oxidation and energy-expenditure responses remained.

The authors concluded that the lipolytic actions were not mediated directly through the beta-3 receptor. Increased receptor expression may contribute to later sensitivity; the experiment does not demonstrate direct receptor binding or human metabolic efficacy.

Cox et al. (2015) investigated in vitro metabolism and analytical detection in biological matrices. Identifying parent peptide and metabolites is an analytical question, distinct from demonstrating biological benefit.

These sources concern mouse experiments and analytical methods. They do not establish human treatment effects, a universal purity threshold, or the contents of the labeled 2 mg preparation. Any certificate assessment must use the exact current product, source document, accession and lot. This article supplies molecule-family research context only.